0000000000054821

AUTHOR

Marie-claude Brindisi

showing 32 related works from this author

Taste disorders in disease

2016

Among the different sensory systems, gustation is one of the most elaborate. In its sensory task, gustation is helped by interactions with other sensory systems (olfaction, vision, audition, and somatosensory, trigeminal and thermal sensations). It allows the detection and identification of soluble compounds which can be ingested or must be avoided. This function is fundamental to ingestive behavior (energy intake and selection of nutrients) in order to meet physiological needs. Taste is also fundamental to the genesis of hedonic sensations and, therefore, the desire to eat (appetite). The tasting step is also the first stage of the digestion, absorption, and storage of nutrients due to ant…

Tastebusiness.industry[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionmedia_common.quotation_subjectGastronomySensory systemAppetiteDiseaseOlfactionmedicine.diseaseMalnutritionTaste disorderMedicinebusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionNeurosciencemedia_common
researchProduct

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type…

2011

Summary Background & aims Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. Although dietary fat contributes substantially to the accumulation of liver fat, the role of individual fatty acids in this accumulation is unclear. Objective In this study, we set out to determine whether liver fat content (LFC), was associated with red blood cell fatty acid (RBC-FA) composition in people with type 2 diabetes. Design, settings, and participants One hundred and sixty-two type 2 diabetic patients were included in this study. LFC was measured using 1H-MR Spectroscopy. RBC-FA composition was measured by gas chromatography. Results One…

Malemedicine.medical_specialtyErythrocytesPalmitic AcidCritical Care and Intensive Care MedicineFatty Acids Monounsaturatedchemistry.chemical_compoundNon-alcoholic Fatty Liver DiseaseFatty Acids Omega-6Internal medicineFatty Acids Omega-3PrevalencemedicineHumansPalmitoleic acidProspective StudiesTriglyceridesAgedchemistry.chemical_classificationNutrition and Dieteticsbusiness.industryFatty liverFatty acidMiddle Agedmedicine.diseaseDietary FatsFatty LiverCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2chemistryDocosahexaenoic acidDietary SupplementsSaturated fatty acidFemaleArachidonic acidSteatosisbusinessPolyunsaturated fatty acidClinical Nutrition
researchProduct

No Improvement of High-Density Lipoprotein (HDL) Vasorelaxant Effect Despite Increase in HDL Cholesterol Concentration in Type 2 Diabetic Patients Tr…

2014

Abstract Context: High-density lipoproteins (HDLs) from type 2 diabetic patients are unable to counteract the inhibitory effect of oxidized low-density lipoproteins (ox-LDLs) on vasorelaxation. We hypothesized that glitazones, which improve glycemic control and dyslipidemia, could correct this abnormality. Objectives and Design: We compared the ability of HDL from controls (n = 12) and from type 2 diabetic patients before and after 6 months of treatment with either rosiglitazone (n = 11) or pioglitazone (n = 8) to counteract the inhibitory effect of ox-LDL on vasodilatation of rabbit aorta rings. Results: Rosiglitazone induced a decrease in hemoglobin A1c (7.7% ± 1.1% vs 9.8% ± 1.0%, P = .0…

Malemedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)BiochemistryRosiglitazonechemistry.chemical_compoundEndocrinologyHigh-density lipoproteinInternal medicineDiabetes mellitusmedicineAnimalsHumansHypoglycemic AgentsThiazolidinedioneAortaAgedDyslipidemiasPioglitazoneCholesterolbusiness.industryCholesterol HDLBiochemistry (medical)Middle Agedmedicine.diseaseLipoproteins LDLVasodilationEndocrinologyDiabetes Mellitus Type 2chemistryFemaleThiazolidinedionesEndothelium VascularRabbitsLipoproteins HDLRosiglitazonebusinessPioglitazoneDyslipidemiamedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct

PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes

2011

Context: Recently, it has been shown that an allele in the adiponutrin (PNPLA3) gene was strongly associated with increased liver fat content (LFC) and liver fibrosis independent of visceral adiposity and insulin resistance. Objective: In this study, we set out to determine whether the PNPLA3 rs738409 polymorphism was associated with liver fibrosis in unselected patients with type 2 diabetes. Design, setting and participants: Two hundred and thirty-four patients with type 2 diabetes were included in this study. Main outcome measures: LFC was evaluated using 1H-MR spectroscopy; fibrosis was measured using the non-invasive FibroTest®. Results: Advanced liver fibrosis (stage F2 or above) was o…

medicine.medical_specialtyeducation.field_of_studyHepatologybusiness.industryFibroTestType 2 diabetesmedicine.diseaseGastroenterologyEndocrinologyInsulin resistanceFibrosisPolymorphism (computer science)Internal medicinemedicineAdiponutrinSteatosisbusinesseducationBody mass indexLiver International
researchProduct

Does weight status increase vulnerability to the food environment?

2022

Obesity is an important public health issue with socioeconomic consequences. Its origin is multifactorial, with environmental, biological, psychological and social dimensions. Furthermore, its consequences involve physical, psychological and social complications on an individual level. The main tool employed to categorize individuals according to their weight status is the body mass index (BMI). This indicator, based on the ratio of weight to height, is used to define what constitutes a "normal" weight status (between 18.5 and 24.9 kg/m 2), overweight (between 25 and 29.9 kg/m 2), and obesity (30 kg/m 2 and above). Current approaches to tackling obesity target a number of actors in the food…

cognitioncognitive[SHS.PSY] Humanities and Social Sciences/Psychologyobesity[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionvulnerability
researchProduct

Étude exploratoire de l’effet d’un amorçage olfactif sur les biais attentionnels chez des adultes normo-pondéraux, en surpoids et obèses

2018

National audience; Introduction Hendrikse et al. [1] mettent en évidence des biais attentionnels (le fait que notre attention soit attirée par certains stimuli plus perceptivement saillants que d’autres dans l’environnement) différents selon le statut pondéral des individus. Ces biais attentionnels sont exacerbés chez les individus en surpoids et obèses face à des stimuli alimentaires à haute densité énergétique [2]. Ces biais semblent jouer un rôle dans le développement et dans le maintien de l'obésité. Notre étude se propose d’étudier les biais attentionnels chez des adultes normo-pondéraux (NP), en surpoids (SP) et obèses (OB) ainsi que les effets d’odeurs alimentaires sur ces biais, en …

cognition[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionchoix alimentairesadultesamorçage olfactif[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionbiais attentionné
researchProduct

Circulating Apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control

2013

SummaryContext Apelin is an adipokine expressed in several tissues and it appears to be involved in energy metabolism. Objective The aim of this study was to determine serum apelin levels in a large cohort of patients with type 1 and type 2 diabetes and control subjects and to correlate the results with glycaemic control. Design and Participants One hundred and thirty patients with type 1 diabetes, 98 patients with type 2 diabetes and 162 controls were enrolled in the study. Apelin levels were measured by enzyme-linked immunosorbent assay. Results Serum apelin levels were significantly higher in type 1 and type 2 diabetic patients than in controls (P < 0·0001). Serum apelin levels were high…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismAdipokineType 2 diabetesEndocrinologyInsulin resistanceInternal medicineDiabetes mellitusmedicineHumansAgedGlycated HemoglobinType 1 diabetesbusiness.industryCase-control studyMiddle Agedmedicine.diseaseObesityUp-RegulationApelinDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2Case-Control StudiesApelinIntercellular Signaling Peptides and ProteinsFemaleInsulin ResistancebusinessBiomarkersClinical Endocrinology
researchProduct

Pravastatin reverses the membrane cholesterol reorganization induced by myocardial infarction within lipid rafts in CD14(+)/CD16(-) circulating monoc…

2012

International audience; Large numbers of monocytes are recruited in the infarcted myocardium. Their cell membranes contain cholesterol-rich microdomains called lipids rafts, which participate in numerous signaling cascades. In addition to its cholesterol-lowering effect, pravastatin has several pleiotropic effects and is widely used as secondary prevention treatment after myocardial infarction (MI). The aim of this study was to investigate the effects of pravastatin on the organization of cholesterol within monocyte membrane rafts from patients who had suffered myocardial infarction. Monocytes from healthy donors and acute MI patients were cultured with or without 4μM pravastatin. Lipid raf…

AdultMalemedicine.medical_specialtyStatinmedicine.drug_classCD14[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionCaveolin 1Lipopolysaccharide Receptors030204 cardiovascular system & hematologyCD16GPI-Linked ProteinsMonocytes03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCaveolaeInternal medicinemedicineHumansMolecular BiologyLipid raftCells Cultured030304 developmental biologyPravastatin0303 health sciencesCholesterolMonocyteAnticholesteremic AgentsReceptors IgGstatinCell BiologyMiddle Aged3. Good healthlipid raftEndocrinologymedicine.anatomical_structureCholesterolmyocardial infarctionchemistryGene Expression RegulationImmunologycaveolaemonocyteFemalelipids (amino acids peptides and proteins)[SDV.AEN]Life Sciences [q-bio]/Food and NutritionPravastatinmedicine.drug
researchProduct

Depression and obesity, data from a national administrative database study: Geographic evidence for an epidemiological overlap

2019

BackgroundDepression and obesity are two major conditions with both psychological and somatic burdens. Some data suggest strong connections between depression and obesity and more particularly associated prevalence of both disorders. However, little is known about the geographical distribution of these two diseases. This study aimed to determine if there is spatial overlap between obesity and depression using data from the entire French territory.MethodsData for 5,627 geographic codes for metropolitan France were collected from the two national hospital databases (PMSI-MCO and RIM-P) for the year 2016. We identified people who were depressed, obese or both registered in the two public medic…

MaleMultivariate analysisSpatial EpidemiologyDatabases FactualPhysiologyEpidemiology[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthSocial SciencesComorbidityGeographical locationsdépression0302 clinical medicineRuralityRisk FactorsEpidemiologyMedicine and Health SciencesPrevalence030212 general & internal medicineDepression (differential diagnoses)Geographic Areas[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMultidisciplinaryGeographyDepressionQRSpatial epidemiology[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Aged3. Good healthEuropeSanté publique et épidémiologieobésitéPhysiological ParametersépidémiologieMedicineFemaleFranceResearch ArticleUrban AreasAdultmedicine.medical_specialtyScienceMédecine humaine et pathologiezone rurale030209 endocrinology & metabolismHuman GeographyUrban Geography03 medical and health sciencesMental Health and PsychiatrymedicineHumansObesityEuropean UnionAgedDepressive Disorder Majorbusiness.industryMood DisordersBody WeightBiology and Life Sciencesdéveloppement épidémiologiqueenvironnement urbainmedicine.diseaseObesityComorbidityRural Areaszone urbaine[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthMultivariate AnalysisEarth SciencesHuman health and pathology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieRural areaPeople and placesbusinessDemographyPLoS ONE
researchProduct

Glycation des HDL et conséquences chez le patient diabétique

2013

Resume Les HDL ont un role majeur dans l’homeostasie vasculaire. Leur action protectrice passe notamment par leur recepteur specifique SR-BI (pour scavenger receptor de classe B type 1 ). La glycation des HDL, phenomene majeur observe au cours d’un diabete, a de nombreuses consequences nefastes vasculaires. La glycation des HDL entraine une augmentation de leur catabolisme, un defaut du transport inverse du cholesterol, une perte de leurs proprietes anti-inflammatoires et anti-oxydantes, notamment sur les LDL oxydees, lipoproteines atherogenes presentes en abondance dans les maladies chroniques. Cliniquement, cela se traduit par une dysfonction endotheliale, phenomene cardiovasculaire delet…

Nutrition and DieteticsGlycationbusiness.industryEndocrinology Diabetes and MetabolismInternal MedicineMedicineCardiology and Cardiovascular MedicinebusinessMolecular biologyMédecine des Maladies Métaboliques
researchProduct

Impacts of emotional regulation and inhibition on Emotional Eating (EE) and Binge Eating Disorder (BED): Protocol for a scoping review

2022

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition
researchProduct

Potential influence of Type A personality on plasma C-reactive protein levels in people with diabetes

2016

IF 4.693; Aim. Type A personality, although classically known as a factor linked to increased vascular risk, has recently been associated with increased survival in patients with diabetes. As low-grade inflammation predicts a poor outcome, the present study explored the potential associations between Type A and plasma levels of C-reactive protein (CRP) in diabetes. Methods. Type A personality was assessed by the Bortner questionnaire in people with diabetes. The association between Type A and plasma CRP levels was examined by multivariable linear regression, and structural equation modelling (SEM) was performed to determine the impact of the major clinical, biological and psychological conf…

MaleEndocrinology Diabetes and Metabolism[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionType 2 diabetesBody Mass Index0302 clinical medicineEndocrinologyc-reactive proteinWeight lossself-care030212 general & internal medicineProspective cohort studymedia_common2. Zero hungerbiologydiabetesGeneral Medicine[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Aged[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismanxiety3. Good healthFemalemedicine.symptomweight-lossAdultmedicine.medical_specialtymedia_common.quotation_subjectprospective cohort030209 endocrinology & metabolism03 medical and health sciencesInternal medicineDiabetes mellitus[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyInternal MedicinemedicineHumansPersonalityAgedGlycated Hemoglobintype abusiness.industrybehaviorC-reactive proteinassociationType A PersonalityType A and Type B personality theorymedicine.disease5-factor modelmortalityEndocrinologyDiabetes Mellitus Type 2personalityinflammationbiology.proteinbusinesscoronary-heart-disease[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBody mass index[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation

2013

Background Contrary to high-density lipoprotein (HDL) from normolipidaemic and normoglycaemic subjects, HDL from diabetic patients loses its ability to reverse the inhibition of vasorelaxation induced by oxidized low-density lipoprotein (LDL). The aim of this study was to analyze the role of glycation, a major abnormality observed in diabetes, on the impairment of the vasorelaxant effect of HDL. Methods HDL from healthy subjects was glycated in vitro by incubation in glucose 200 mmol/L for 3 days. Vasoreactivity was evaluated by the relaxation response to acetylcholine of rabbit aorta rings pre-contracted with noradrenaline, before and after 2 h incubation with or without different lipoprot…

medicine.medical_specialtyEndotheliumbusiness.industryEndocrinology Diabetes and MetabolismVasodilationmedicine.diseasechemistry.chemical_compoundEndocrinologymedicine.anatomical_structureEndocrinologyFructosaminechemistryGlycationInternal medicineDiabetes mellitusInternal Medicinemedicinelipids (amino acids peptides and proteins)businessIncubationAcetylcholinemedicine.drugLipoproteinDiabetes/Metabolism Research and Reviews
researchProduct

Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients

2021

Abstract Obesity is increasing in patients with type 2 diabetes. A possible reduced association between fructosamine and glycated hemoglobin (HbA1c) in obese individuals has been previously discussed, but this has never been specifically evaluated in type 2 diabetes, and the potential influence of body fat mass and fat distribution has never been studied. We studied 112 type 2 diabetes patients with assessment of fat mass, liver fat and fat distribution. Patients with body mass index (BMI) above the median (34.9 kg/m2), versus BMI below the median, had a correlation coefficient between fructosamine and HbA1c significantly reduced (r = 0.358 vs r = 0.765). In the whole population, fructosami…

Maleendocrine system diseasesEndocrinology Diabetes and MetabolismType 2 diabetesObesechemistry.chemical_compound0302 clinical medicineProspective Studies2. Zero hunger[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismeducation.field_of_studyDiabetesGeneral MedicineArticles[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle AgedMagnetic Resonance ImagingFructosamineClinical Science and Care030220 oncology & carcinogenesisFructosamineFemalemedicine.medical_specialtyPopulationShort ReportAbdominal Fat030209 endocrinology & metabolismDiseases of the endocrine glands. Clinical endocrinologyFat mass03 medical and health sciencesDiabetes mellitusInternal medicineInternal MedicinemedicineHumansObesityeducationAgedGlycated Hemoglobinbusiness.industrynutritional and metabolic diseasesmedicine.diseaseRC648-665ObesityEndocrinologychemistryDiabetes Mellitus Type 2Glycated hemoglobinbusinessBody mass indexJournal of Diabetes Investigation
researchProduct

Qualité de l'évaluation de l'état nutritionnel et évaluation de l'observance des compléments nutritionnels oraux chez des patients hospitalisés au CH…

2017

International audience

[ SHS ] Humanities and Social Sciences[SHS] Humanities and Social SciencesComputingMilieux_MISCELLANEOUS[SHS]Humanities and Social Sciences
researchProduct

Comportement alimentaire, facteurs psychosociaux et Indice de Masse Corporelle

2021

International audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

[Hedonic perception and taste of food in patients with type 2 diabetes - Impact of treatment with a GLP-1: Liraglutide] / P19 Perception hédonique et…

2012

Special Issue 2 : Résumés des communications de la réunion scientifique de la SFD, de la SFD Paramédical et de l'AJD ; WOS: 000302819400145; International audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Différences de capacités de contrôle face aux aliments chez des individus normo-pondéraux, en surpoids et en obésité

2020

International audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Influence du liraglutide (analogue du GLP-1) sur les caractéristiques hédoniques de la prise alimentaire et les performances gustatives, chez les pat…

2011

sensorialité gustativeobésité[SDV.AEN] Life Sciences [q-bio]/Food and Nutritiondiabète de type 2comportement alimentaire[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

P003. Histoire pondérale de 238 femmes souffrant d'anorexie mentale ou de boulimie

2010

Poster affiché ; http://www.jfn2010.com

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionComputingMethodologies_GENERAL[SDV.AEN]Life Sciences [q-bio]/Food and NutritionGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)ComputingMilieux_MISCELLANEOUS
researchProduct

La place des Compléments Nutritionnels Oraux dans le processus de soins à l'hôpital : évaluation des pratiques professionnelles et des représentations

2018

International audience; L’évaluation nutritionnelle et le dépistage de la dénutrition se basent sur des critères recommandés par les instances de santé. En pratique, ces recommandations ne sont pas toujours bien appliquées par les soignants. Lorsqu’un patient est dénutri et que la mise en place d’une complémentation nutritionnelle orale a lieu, les discours des soignants vis-à-vis des CNO sont divers. Leur statut peut alors manquer de clarté pour les soignants comme pour les patients et c’est pourquoi il est nécessaire que leurs rôles et leurs fonctions soient explicités, cohérents et compris par chacun. Cet article a pour but de faire l’état des lieux des pratiques professionnelles autour …

dénutritionhospitalisation[SHS] Humanities and Social Sciencesétat nutritionnelcomplémentation nutritionnelle orale (CNO)représentations alimentaires[SHS]Humanities and Social Sciences
researchProduct

People with insulin-treated diabetes have achieved an original educational program for the use of flash glucose monitoring: results from a cohort of …

2020

International audience

[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismComputingMilieux_MISCELLANEOUS
researchProduct

Développement d’une mesure d’orientation de l’attention visuelle vers des stimuli alimentaires : Adaptation de la Visual Probe Task

2018

National audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Hedonic perception and taste of food in patients with type 2 diabetes - Impact of treatment with a GLP-1: Liraglutide.

2012

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition
researchProduct

Attentional biases toward food pictures: influence of olfactory priming according to weight status

2018

International audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Use of added sugar, salt and fat in the first year in France and associated factors in the ELFE cohort study

2018

National audience; Background and Aims: To describe added sugar, salt and fat uses and their determinants during complementary feeding (CF) period in infants aged 3 to 10 months. Methods: Data are drawn from the ELFE study (Etude longitudinale Française depuis l'Enfance) which included >18000 infants in 2011. A frequency food questionnaire of consumption of added sugar, salt and fat was monthly completed by the mother from the 3rd to the 10th month (N=10,649). The associations between the use of each added-ingredient and (1) socio-economic characteristics and (2) infant care and feeding practices were studied with two models (the second including the factors of the first) with multivariate …

[SDV.AEN] Life Sciences [q-bio]/Food and NutritionsugarfatELFE studysaltcomplementary feeding practices[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Anorexie mentale : analyse des réponses sensorielles et hédoniques explicites et implicites en réponse à des stimulations olfactives et visuelles et …

2009

National audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Gustatory evoked potentials and cerebral control of food intake in obese subjects (PEGASE study)

2018

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Treatment by GLP-1 agonist modulates hedonic response to food and taste sensitivity in type 2 diabetes

2012

Context: Besides their potential action in the treatment of type 2 diabetes mellitus (T2DM), GLP-1 analogues have been shown to decrease satiety and food intake. However, little is known about their effects on food hedonic and taste perceptions. Objective: The objective of the study was to investigate the impact of GLP-1 analogue Liraglutide on the liking and wanting component of the food reward system as well as on taste sensitivity in T2DM patients. . Research design and methods: Thirty T2DM patients were studied before and after 3 months of daily Liraglutide treatment (1.2 mg). In each trial, blood samples were collected and body mass composition was analyzed by dual-energy X-ray absorpt…

GLP-1 analogue[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionlikingnutrition[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionsatietydigestive oral and skin physiology[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologygustationPHARMACOLOGY & PHARMACY[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Histoire pondérale de 238 femmes souffrant d'anorexie mentale ou de boulimie

2010

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Influence d’un amorçage olfactif chez des adultes de statut pondéral diffèrent

2019

National audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Influence du liraglutide (analogue du GLP-1) sur les caractéristiques hédoniques de la prise alimentaire et les performances gustatives, chez les pat…

2011

Titre anglais : Treatment by GLP-1 agonist modulates hedonic responses to food and taste sensitivity in obese type 2 diabetes mellitus patients

[SDV] Life Sciences [q-bio][ SDV ] Life Sciences [q-bio][SDV]Life Sciences [q-bio]digestive oral and skin physiology
researchProduct